annual shareholders equity:
$754.90M-$173.02M(-18.65%)Summary
- As of today (July 1, 2025), XENE annual stockholders equity is $754.90 million, with the most recent change of -$173.02 million (-18.65%) on December 31, 2024.
- During the last 3 years, XENE annual shareholders equity has risen by +$204.87 million (+37.25%).
- XENE annual shareholders equity is now -18.65% below its all-time high of $927.92 million, reached on December 31, 2023.
Performance
XENE Shareholders equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly shareholders equity:
$703.96M-$50.95M(-6.75%)Summary
- As of today (July 1, 2025), XENE quarterly stockholders equity is $703.96 million, with the most recent change of -$50.95 million (-6.75%) on March 31, 2025.
- Over the past year, XENE quarterly shareholders equity has dropped by -$183.74 million (-20.70%).
- XENE quarterly shareholders equity is now -24.14% below its all-time high of $927.92 million, reached on December 31, 2023.
Performance
XENE quarterly shareholders equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Shareholders equity Formula
Shareholders Equity = Total Assets − Total Liabilities
XENE Shareholders equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -18.6% | -20.7% |
| 3 y3 years | +37.3% | +29.9% |
| 5 y5 years | +720.8% | +274.5% |
XENE Shareholders equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -18.6% | +37.3% | -24.1% | +10.6% |
| 5 y | 5-year | -18.6% | +720.8% | -24.1% | +310.8% |
| alltime | all time | -18.6% | +5880.4% | -24.1% | +2819.1% |
XENE Shareholders equity History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $703.96M(-6.7%) |
| Dec 2024 | $754.90M(-18.6%) | $754.90M(-5.4%) |
| Sep 2024 | - | $797.81M(-5.5%) |
| Jun 2024 | - | $844.05M(-4.9%) |
| Mar 2024 | - | $887.70M(-4.3%) |
| Dec 2023 | $927.92M(+28.6%) | $927.92M(+45.8%) |
| Sep 2023 | - | $636.59M(-1.5%) |
| Jun 2023 | - | $646.46M(-5.9%) |
| Mar 2023 | - | $686.94M(-4.8%) |
| Dec 2022 | $721.50M(+31.2%) | $721.50M(-4.2%) |
| Sep 2022 | - | $753.12M(-4.2%) |
| Jun 2022 | - | $785.79M(+45.0%) |
| Mar 2022 | - | $541.85M(-1.5%) |
| Dec 2021 | $550.03M(+221.0%) | $550.03M(+121.0%) |
| Sep 2021 | - | $248.94M(-3.1%) |
| Jun 2021 | - | $256.98M(-7.0%) |
| Mar 2021 | - | $276.28M(+61.2%) |
| Dec 2020 | $171.35M(+86.3%) | $171.35M(-5.9%) |
| Sep 2020 | - | $182.02M(-3.8%) |
| Jun 2020 | - | $189.30M(+0.7%) |
| Mar 2020 | - | $187.98M(+104.4%) |
| Dec 2019 | $91.98M | $91.98M(+23.4%) |
| Sep 2019 | - | $74.56M(-9.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2019 | - | $82.79M(-10.3%) |
| Mar 2019 | - | $92.31M(-10.6%) |
| Dec 2018 | $103.30M(+187.5%) | $103.30M(-7.1%) |
| Sep 2018 | - | $111.16M(+119.6%) |
| Jun 2018 | - | $50.62M(+77.6%) |
| Mar 2018 | - | $28.50M(-20.7%) |
| Dec 2017 | $35.93M(-43.8%) | $35.93M(-17.0%) |
| Sep 2017 | - | $43.30M(-14.2%) |
| Jun 2017 | - | $50.45M(-11.8%) |
| Mar 2017 | - | $57.20M(-10.5%) |
| Dec 2016 | $63.90M(+4.7%) | $63.90M(-7.8%) |
| Sep 2016 | - | $69.31M(+31.6%) |
| Jun 2016 | - | $52.66M(-9.5%) |
| Mar 2016 | - | $58.16M(-4.7%) |
| Dec 2015 | $61.03M(-16.1%) | $61.03M(-5.3%) |
| Sep 2015 | - | $64.46M(+0.2%) |
| Jun 2015 | - | $64.35M(-6.7%) |
| Mar 2015 | - | $68.97M(-5.2%) |
| Dec 2014 | $72.78M(+201.8%) | $72.78M(+108.1%) |
| Sep 2014 | - | $34.98M(+29.0%) |
| Jun 2014 | - | $27.11M(+12.4%) |
| Dec 2013 | $24.12M(+91.0%) | $24.12M |
| Dec 2012 | $12.62M | - |
FAQ
- What is Xenon Pharmaceuticals annual stockholders equity?
- What is the all time high annual shareholders equity for Xenon Pharmaceuticals?
- What is Xenon Pharmaceuticals annual shareholders equity year-on-year change?
- What is Xenon Pharmaceuticals quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Xenon Pharmaceuticals?
- What is Xenon Pharmaceuticals quarterly shareholders equity year-on-year change?
What is Xenon Pharmaceuticals annual stockholders equity?
The current annual shareholders equity of XENE is $754.90M
What is the all time high annual shareholders equity for Xenon Pharmaceuticals?
Xenon Pharmaceuticals all-time high annual stockholders equity is $927.92M
What is Xenon Pharmaceuticals annual shareholders equity year-on-year change?
Over the past year, XENE annual stockholders equity has changed by -$173.02M (-18.65%)
What is Xenon Pharmaceuticals quarterly stockholders equity?
The current quarterly shareholders equity of XENE is $703.96M
What is the all time high quarterly shareholders equity for Xenon Pharmaceuticals?
Xenon Pharmaceuticals all-time high quarterly stockholders equity is $927.92M
What is Xenon Pharmaceuticals quarterly shareholders equity year-on-year change?
Over the past year, XENE quarterly stockholders equity has changed by -$183.74M (-20.70%)